Dear all

Facing challenging times has rather been the norm for the critical care community and now we stand to face yet another in the wake of COVID-19. While we may all be exceptionally good at clinical management of organ failures, I urge everyone to take utmost precautions with respect to infection control and the health of our fellow colleagues, subordinates and families. Let us be prudent when it comes to sharing information on social media as there seems to be so much noise and cue already out there, both good and bad. Our healthcare systems have been working in close cooperation with governmental agencies in a scientific manner and this is no time for criticism or conflict. The Health and Family Welfare Department, Government of Tamil Nadu has provided us with handy guidelines and forms for clinical and epidemiological use. Likewise, the Ministry of Health and Family Welfare, Government of India has also come up with its Guidelines on Clinical Management of COVID – 19 (dated 17th March 2020) and you can look them up on our hyperlink. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Corona Virus Disease 2019 (COVID-19) provides a provisional document on expert panel recommendations to aid healthcare providers caring for the critically ill patient with COVID – 19.

The strategies for testing and treatment are being periodically revised and you may feel free to mail us for any queries on latest updates. You may also visit for latest health advisories and notifications. I wish to reiterate the relevance of each institute, at this time point, to execute preparedness checks and mock drills including training on donning and doffing of PPEs and ensuring adequate stocks. The Hospital Readiness Checklist by the WHO and the ICU Preparedness Checklist by the SCCM may serve as useful resources. I also would like to stress upon the maintenance of a diligent patient database for scientific inquiry and future governance. Together let us conquer.

Dr. Raymond Dominic Savio

ISCCM Chennai.